Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 12 Jun 2026 for ARS Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Eric Karas: trading record in brief
Eric Karas is a declared insider of ARS Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 8 filings cover trades dated from 19 August 2024 to 12 June 2026.
The open-market record consists of 1 sale, with no purchase. The totals do not cover 1 filing with an undisclosed amount. The rest of the record consists of 7 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 12 June 2026, reports an option exercise in ARS Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Karas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
25,000 sharesCommon StockSEC:0001951287-26-000004:0
25,000 sharesCommon StockSEC:0001951287-26-000004:1
15,000 shares@ US$1.5022.5% of flowCommon StockSEC:0001415889-25-019321:0
15,000 shares@ US$1.5023.1% of flowCommon StockSEC:0001415889-25-017901:0
10,000 shares@ US$1.5016.2% of flowCommon StockSEC:0001415889-25-008796:0
3,717 shares@ US$1.506.2% of flowCommon StockSEC:0001415889-24-028349:0
10,000 shares@ US$1.5015.9% of flowCommon StockSEC:0001415889-24-023712:0
10,000 shares@ US$1.5016.0% of flowCommon StockSEC:0001415889-24-021885:0
8 of 8 declarations
